Based on the diagnostic criteria of WHO, trials such as the administration of avatrombopag to patients with thrombocytopenia were bundled when they achieved the following criteria: one) Study design:Nevertheless, individuals on avatrombopag weren't observed to own greater amounts of activated circulating platelets, as measured with flow cytometry.